JDD Article Highlights
Triple-combination therapies for acne are known for their efficacy, but the complexity of multiple treatments often reduces patient adherence. Enter CAB gel (Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%; Cabtreo®, Ortho Dermatologics), the first FDA-approved triple-combination topical for acne. This fixed-dose gel simplifies the regimen by combining three potent ingredients into one easy-to-apply treatment.
This article in JDD showcases a recent split-face study, participants found CAB gel faster, easier, and more even to apply compared to layering individual ingredients. With improved application ease, CAB gel could enhance both adherence and treatment outcomes.
